
    
      This is a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of
      Efficacy and Safety of Enzalutamide in Combination With Exemestane in Patients With Advanced
      Breast Cancer That Is Estrogen or Progesterone Receptor Positive and HER2-Normal.
    
  